Abstract
Pulmonary embolism (PE) and deep vein thrombosis (DVT) are widely regarded as manifestations of a single disease, venous thromboembolism (VTE). An evidence-based approach to the treatment of acute VTE will be reviewed here. Currently available therapeutic options will be emphasized; possible future treatment approaches will be discussed briefly. The chronic management of VTE involves assessment of the risks and benefits of prolonged anticoagulation and is discussed in more detail elsewhere in this issue.
Keywords: Venous thromboembolism, anticoagulation, thrombolysis, Pulmonary embolism, deep vein thrombosis, vitamin K antagonists, rapid-acting gly-cosaminoglycan agent, fondaparinux, low molecular weight heparin, thrombolytic therapy, activated partial throm-boplastin time, idiopathic VTE, Systemic Thrombolysis, Pulmonary Embolectomy, Dalteparin, Enoxaparin, Tinzaparin, Inferior Vena Cava Interruption, craniotomy, caval thrombosis, DVT, tPA-induced bleeding, thrombotic syndrome, Statins, HmGCoA Reductase inhibitors, C-reactive protein, Aspirin, arterial thrombotic events, myocardial infarction, VKA-based anticoagulation, warfarin
Current Pharmaceutical Design
Title: Current Therapeutic Strategies and Future Perspectives for the Treatment of Venous Thromboembolism
Volume: 16 Issue: 31
Author(s): David A. Garcia
Affiliation:
Keywords: Venous thromboembolism, anticoagulation, thrombolysis, Pulmonary embolism, deep vein thrombosis, vitamin K antagonists, rapid-acting gly-cosaminoglycan agent, fondaparinux, low molecular weight heparin, thrombolytic therapy, activated partial throm-boplastin time, idiopathic VTE, Systemic Thrombolysis, Pulmonary Embolectomy, Dalteparin, Enoxaparin, Tinzaparin, Inferior Vena Cava Interruption, craniotomy, caval thrombosis, DVT, tPA-induced bleeding, thrombotic syndrome, Statins, HmGCoA Reductase inhibitors, C-reactive protein, Aspirin, arterial thrombotic events, myocardial infarction, VKA-based anticoagulation, warfarin
Abstract: Pulmonary embolism (PE) and deep vein thrombosis (DVT) are widely regarded as manifestations of a single disease, venous thromboembolism (VTE). An evidence-based approach to the treatment of acute VTE will be reviewed here. Currently available therapeutic options will be emphasized; possible future treatment approaches will be discussed briefly. The chronic management of VTE involves assessment of the risks and benefits of prolonged anticoagulation and is discussed in more detail elsewhere in this issue.
Export Options
About this article
Cite this article as:
A. Garcia David, Current Therapeutic Strategies and Future Perspectives for the Treatment of Venous Thromboembolism, Current Pharmaceutical Design 2010; 16 (31) . https://dx.doi.org/10.2174/138161210793563347
DOI https://dx.doi.org/10.2174/138161210793563347 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subclinical Hypothyroidism and Homeostatic Disturbances: Case Report and Literature Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Is there Evidence to Support the Use of Direct Factor Xa Inhibitors in Coronary Artery Disease?
Reviews on Recent Clinical Trials Pharmacokinetics and Pharmacodynamics of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor
Current Clinical Pharmacology Acute Antithrombotic Treatment of Ischemic Stroke
Current Vascular Pharmacology Postmenopausal Hormone Therapy
Current Women`s Health Reviews Review of the Pharmacology of the Emerging Possibilities of the Direct Oral Anticoagulants' Reversal
Current Drug Metabolism First-Line Treatment of Multiple Myeloma in Elderly Patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dellAdulto) Multiple Myeloma Working Party Perspective
Current Drug Targets Multimodality Imaging in Acute Ischemic Stroke
Current Medical Imaging Key Advances in MIP-based Sensors Applied for Cancer and Cardiovascular Biomarkers Detection
Current Topics in Medicinal Chemistry Recurrent Gastrointestinal Bleeding in a Patient with Eisenmenger Syndrome Using Bosentan
Current Drug Safety Recent Developments in Female Hormonal Contraception
Current Women`s Health Reviews The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) Clinical Evidence and Therapeutic Treatments at the Time of the Coronaviruses Responsible for SARS: A Perspective and Points of view with a Focus on Vascular Endothelium
Coronaviruses Diagnostic Performance of Magnetic Resonance Cholangiopancreatography (MRCP) for Biliopancreatic Cancer
Current Medical Imaging Novel Nanostructured Polymeric Carriers to Enable Drug Delivery for Cardiovascular Diseases
Current Pharmaceutical Design New Substrate Analogue Inhibitors of Factor Xa Containing 4-Amidinobenzylamide as P1 Residue: Part 1
Medicinal Chemistry Prevention and Management of Ovarian Hyperstimulation Syndrome
Current Women`s Health Reviews Candidate Circulating Biomarkers for the Cardiovascular Disease Continuum
Current Pharmaceutical Design Neuroprotective Effects of Ginkgolide B Against Ischemic Stroke: A Review of Current Literature
Current Topics in Medicinal Chemistry Metallocarboxypeptidases: Emerging Drug Targets in Biomedicine
Current Pharmaceutical Design